What is the ROCE (Return on Capital Employed) of Qiagen this year?
The ROCE of Qiagen is 0.12 undefined this year.
Qiagen ROCE 2024
Qiagen ROCE
0.12
Ticker
QGEN
ISIN
NL0012169213
WKN
A2DKCH
In 2024, Qiagen's return on capital employed (ROCE) was 0.12, a -29.65% increase from the 0.17 ROCE in the previous year.
Qiagen Aktienanalyse
What does Qiagen do?
Qiagen NV is a biotechnology company based in Venlo, Netherlands. The company was founded in 1984 as a spin-off from the University of Düsseldorf and has since become a leading provider of molecular diagnostic products and systems. Qiagen operates in four business areas: Life Sciences, Molecular Diagnostics, Applied Testing, and Pharma. Life Sciences is the largest business area of the company and offers a wide range of products for DNA sequencing, gene expression, RNA isolation and analysis, as well as protein analysis. Molecular Diagnostics specializes in diagnostic tests for diseases such as cancer, infections, and genetic disorders. Applied Testing provides solutions for forensic analysis and food and environmental analysis, while Pharma offers products and services for drug discovery and development. In recent years, Qiagen has focused mainly on the development of molecular diagnostic tests for cancer and infection-related diseases such as HIV, hepatitis, and tuberculosis. These tests enable earlier detection of diseases and more targeted therapy, improving patient care and reducing healthcare costs. One example of a successful Qiagen product is the Cobas HPV Test, a molecular diagnostic test for the detection of human papillomaviruses (HPV) responsible for cervical cancer. The test is distributed by Roche Diagnostics and is one of the best-selling molecular diagnostic tests in the world. Qiagen also has a strong presence in academic research and is a major provider of tools and technologies for DNA sequencing and genome research. Customers include leading research institutes, universities, and pharmaceutical companies. In recent years, Qiagen has also expanded through acquisitions to expand its offering of products and technologies and enter new markets. For example, in 2018, the company acquired N-of-One, a provider of artificial intelligence in cancer diagnostics, and NeuMoDx Molecular, a provider of molecular diagnostic platforms for laboratories. In 2020, Qiagen also played a crucial role in the development of tests for the new coronavirus (SARS-CoV-2). The company, together with other leading diagnostic companies, developed molecular diagnostic tests for rapid and reliable diagnosis of COVID-19. Overall, Qiagen is an important player in the biotech industry, offering a wide range of products and services for molecular diagnostics, genome research, and pharmaceutical research. Qiagen has a strong competitive position due to its innovative products and technologies, strong presence in academic research, and strategic acquisitions to expand its product portfolio and market access. Qiagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Qiagen's Return on Capital Employed (ROCE)
Qiagen's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Qiagen's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Qiagen's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Qiagen’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Qiagen stock
How has the ROCE (Return on Capital Employed) of Qiagen developed compared to the previous year?
The ROCE of Qiagen has increased by -29.65% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Qiagen?
A high Return on Capital Employed (ROCE) indicates that Qiagen has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Qiagen?
A low ROCE (Return on Capital Employed) can indicate that Qiagen has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Qiagen impact the company?
An increase in the ROCE of Qiagen can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Qiagen affect the company?
A decrease in ROCE of Qiagen can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Qiagen?
Some factors that can affect Qiagen's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Qiagen so important for investors?
The ROCE of Qiagen is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Qiagen take to improve the ROCE?
To improve the ROCE, Qiagen can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Qiagen pay?
Over the past 12 months, Qiagen paid a dividend of 1.08 USD . This corresponds to a dividend yield of about 2.43 %. For the coming 12 months, Qiagen is expected to pay a dividend of 0 USD.
What is the dividend yield of Qiagen?
The current dividend yield of Qiagen is 2.43 %.
When does Qiagen pay dividends?
Qiagen pays a quarterly dividend. This is distributed in the months of February, February, February, February.
How secure is the dividend of Qiagen?
Qiagen paid dividends every year for the past 5 years.
What is the dividend of Qiagen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Qiagen located?
Qiagen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Qiagen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Qiagen from 2/1/2024 amounting to 1.32 USD, you needed to have the stock in your portfolio before the ex-date on 1/30/2024.
When did Qiagen pay the last dividend?
The last dividend was paid out on 2/1/2024.
What was the dividend of Qiagen in the year 2023?
In the year 2023, Qiagen distributed 0 USD as dividends.
In which currency does Qiagen pay out the dividend?
The dividends of Qiagen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Qiagen stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Qiagen
Our stock analysis for Qiagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qiagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.